Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SPRO | Spero Therapeutics, Inc. | Director | $79.8K | May 29, 2024 | ||
LRMR | Larimar Therapeutics, Inc. | Director | $22K | +$22K | May 29, 2024 | |
ORTX | Orchard Therapeutics plc | Title: President & Chief Operating Officer | Jan 24, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|